Canadian Manufacturing

Kontrol BioCloud adds Canadian supplier of antibodies to its supply chain

by CM Staff   

Manufacturing Operations Supply Chain Technology / IIoT COVID-19 distribution In Focus Manufacturing medical manufacturing pandemic pharmaceuticals supply chain Technology


Kontrol has been actively seeking stable supply partners and based on its most recent lab testing has selected a Canadian manufacturer for larger quantity purchases.

TORONTO — Kontrol Technologies Corp., a company involved in smart buildings and cities through IoT, Cloud and SaaS technology announces that it continues to make progress in adding to its strategic supply chain capacity for BioCloud. With the addition of Canadian antibody supply, Kontrol is adding to its necessary supply chain and manufacturing partners required to meet its anticipated demand from its distribution network and direct customers.

At the heart of the BioCloud technology is a viral detection system which utilizes antibodies to identify the SARS-CoV-2 virus. Kontrol has been actively seeking stable supply partners and based on its most recent lab testing has selected a Canadian manufacturer for larger quantity purchases. The Canadian manufacturer will not be disclosed at this time for industry competitive purposes.

“Sourcing high quality North American and specifically Canadian supply of antibodies has been an ongoing priority for BioCloud,” said Paul Ghezzi, CEO of Kontrol. “This is a process which requires lab resources and time to test each potential antibody selection. Following a rigorous review and testing process, we are pleased to have the capability to source larger antibody volumes with a trusted Canadian manufacturer.”

Kontrol BioCloud also recently entered into a Non-Disclosure Agreement (NDA) with a global leading HVAC and building controls company to review the addition of BioCloud to the Company’s operating platform. The Company has revenues in excess of $30 Billion USD per annum and operates in thousands of institutional, commercial, and industrial buildings globally. Under the NDA, Kontrol BioCloud will share all of its testing and lab data.

Advertisement

Kontrol BioCloud Enters into Distribution Discussions in Japan Through the Canadian Trade Commissioners Office

Kontrol is in active discussions with two potential distribution partners for Japan. The introductions were made through the Canadian Trade Commissioners Office.

Advertisement

Stories continue below